These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22402736)

  • 1. Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function.
    Aicher BO; Haser EK; Freeman LA; Carnie AV; Stonik JA; Wang X; Remaley AT; Kato GJ; Cannon RO
    Obesity (Silver Spring); 2012 Oct; 20(10):2057-62. PubMed ID: 22402736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity.
    Kjellmo CA; Karlsson H; Nestvold TK; Ljunggren S; Cederbrant K; Marcusson-Ståhl M; Mathisen M; Lappegård KT; Hovland A
    J Clin Lipidol; 2018; 12(1):193-202. PubMed ID: 29146227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol.
    Stefanick ML; Mackey S; Sheehan M; Ellsworth N; Haskell WL; Wood PD
    N Engl J Med; 1998 Jul; 339(1):12-20. PubMed ID: 9647874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome.
    Dokras A; Playford M; Kris-Etherton PM; Kunselman AR; Stetter CM; Williams NI; Gnatuk CL; Estes SJ; Sarwer DB; Allison KC; Coutifaris C; Mehta N; Legro RS
    Clin Endocrinol (Oxf); 2017 May; 86(5):739-746. PubMed ID: 28199736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of Almonds in a Cholesterol-Lowering Diet Improves Plasma HDL Subspecies and Cholesterol Efflux to Serum in Normal-Weight Individuals with Elevated LDL Cholesterol.
    Berryman CE; Fleming JA; Kris-Etherton PM
    J Nutr; 2017 Aug; 147(8):1517-1523. PubMed ID: 28615375
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic Value of the Modified Atherogenic Index of Plasma during Body Mass Reduction in Polish Obese/Overweight People.
    Zalejska-Fiolka J; Hubková B; Birková A; Veliká B; Puchalska B; Kasperczyk S; Błaszczyk U; Fiolka R; Bożek A; Maksym B; Mareková M; Birkner E
    Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30591697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary intake and changes in lipoprotein lipids in obese, postmenopausal women placed on an American Heart Association Step 1 diet.
    Bunyard LB; Dennis KE; Nicklas BJ
    J Am Diet Assoc; 2002 Jan; 102(1):52-7. PubMed ID: 11794502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein cholesterol efflux, nitration of apolipoprotein A-I, and endothelial function in obese women.
    Vazquez E; Sethi AA; Freeman L; Zalos G; Chaudhry H; Haser E; Aicher BO; Aponte A; Gucek M; Kato GJ; Waclawiw MA; Remaley AT; Cannon RO
    Am J Cardiol; 2012 Feb; 109(4):527-32. PubMed ID: 22105786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of high-, moderate-, and low-fat diets on weight loss and cardiovascular disease risk factors.
    Fleming RM
    Prev Cardiol; 2002; 5(3):110-8. PubMed ID: 12091753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.
    Maki KC; Beiseigel JM; Jonnalagadda SS; Gugger CK; Reeves MS; Farmer MV; Kaden VN; Rains TM
    J Am Diet Assoc; 2010 Feb; 110(2):205-14. PubMed ID: 20102847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of exercise in modulating the impact of an ultralow-fat diet on serum lipids and apolipoproteins in patients with or at risk for coronary artery disease.
    Marshall DA; Vernalis MN; Remaley AT; Walizer EM; Scally JP; Taylor AJ
    Am Heart J; 2006 Feb; 151(2):484-91. PubMed ID: 16442919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The obesity paradox, weight loss, and coronary disease.
    Lavie CJ; Milani RV; Artham SM; Patel DA; Ventura HO
    Am J Med; 2009 Dec; 122(12):1106-14. PubMed ID: 19682667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of ezetimibe and orlistat, alone or in combination, on high-density lipoprotein (HDL) subclasses and HDL-associated enzyme activities in overweight and obese patients with hyperlipidaemia.
    Nakou ES; Filippatos TD; Kiortsis DN; Derdemezis CS; Tselepis AD; Mikhailidis DP; Elisaf MS
    Expert Opin Pharmacother; 2008 Dec; 9(18):3151-8. PubMed ID: 19040336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY; Gümüşlü S; Semiz E
    Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacities.
    Attia N; Fournier N; Vedie B; Cambillau M; Beaune P; Ziegler O; Grynberg A; Paul JL; Guerci B
    Atherosclerosis; 2010 Apr; 209(2):422-9. PubMed ID: 19837407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exercise and training alter blood lipid and lipoprotein profiles differently in overweight and obese men and women.
    Greene NP; Martin SE; Crouse SF
    Obesity (Silver Spring); 2012 Aug; 20(8):1618-27. PubMed ID: 22421926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression.
    Kuvin JT; Rämet ME; Patel AR; Pandian NG; Mendelsohn ME; Karas RH
    Am Heart J; 2002 Jul; 144(1):165-72. PubMed ID: 12094204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aerobic training with and without weight loss on insulin sensitivity and lipids.
    Swift DL; Houmard JA; Slentz CA; Kraus WE
    PLoS One; 2018; 13(5):e0196637. PubMed ID: 29775461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.